EZZ Life Science Holdings Ltd (EZZ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EZZ Life Science Holdings Ltd (EZZ) has a cash flow conversion efficiency ratio of -0.198x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.50 Million ≈ $-3.89 Million USD) by net assets (AU$27.81 Million ≈ $19.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EZZ Life Science Holdings Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how EZZ Life Science Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of EZZ Life Science Holdings Ltd for a breakdown of total debt and financial obligations.
EZZ Life Science Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EZZ Life Science Holdings Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alma Metals Ltd
AU:ALM
|
0.228x |
|
Higher Way Electronic Co Ltd
TWO:3268
|
-0.040x |
|
authID Inc.
NASDAQ:AUID
|
-0.382x |
|
Pion Group AB Series B
ST:PION-B
|
-0.103x |
|
WiMi Hologram Cloud Inc
NASDAQ:WIMI
|
0.044x |
|
Metal Energy Corp
V:MERG
|
0.042x |
|
Hubei Geoway Investment Co Ltd
SHG:600462
|
0.893x |
|
Keller Group PLC
LSE:KLR
|
0.077x |
Annual Cash Flow Conversion Efficiency for EZZ Life Science Holdings Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of EZZ Life Science Holdings Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see EZZ company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$28.09 Million ≈ $19.87 Million |
AU$4.35 Million ≈ $3.08 Million |
0.155x | -46.20% |
| 2023-12-31 | AU$21.32 Million ≈ $15.09 Million |
AU$6.14 Million ≈ $4.35 Million |
0.288x | +4.67% |
| 2022-12-31 | AU$14.58 Million ≈ $10.32 Million |
AU$4.01 Million ≈ $2.84 Million |
0.275x | +64.84% |
| 2021-12-31 | AU$11.39 Million ≈ $8.06 Million |
AU$1.90 Million ≈ $1.35 Million |
0.167x | +565.80% |
| 2020-12-31 | AU$10.11 Million ≈ $7.15 Million |
AU$253.53K ≈ $179.39K |
0.025x | -93.38% |
| 2019-12-31 | AU$7.85 Million ≈ $5.56 Million |
AU$2.97 Million ≈ $2.10 Million |
0.379x | -25.04% |
| 2018-12-31 | AU$823.91K ≈ $582.97K |
AU$416.33K ≈ $294.58K |
0.505x | -- |
About EZZ Life Science Holdings Ltd
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consum… Read more